home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Drug Safety Surveillance and Epidemiology

 
  June 04, 2008  
     
 
Drug Information Association, Four Points by Sheraton, Washington DC, USA
Sep 8 2008


This course is designed to provide an overview of US and international safety surveillance, including the role of epidemiology and risk management, from both industry and FDA perspectives. This overview is not a “how to” course in completing adverse event forms for regulatory reporting. •The role of epidemiology in safety surveillance •Domestic and international safety surveillance •Regulatory and industry perspectives on safety surveillance and epidemiology.
 
 
Organized by: Drug Information Association
Invited Speakers:

Steven J. Blumenthal, MSAssociate Director, Safety Update ReportingMerck Research LaboratoriesUnited States 

Linda S HostelleyVice President, Worldwide Product Safety and Quality AssuranceMerck & Co., Inc.United States 

Judith M Sills, PharmDVice President & Head of Medical Safety OperationsNovartis Pharmaceuticals CorporationUnited States 

I. Sanford Smith, MDUnited States 

Annette Stemhagen, Dr PH, FISPEVice President, Epidemiology and Risk ManagementUnited Biosource CorporationUnited States.

 
Deadline for Abstracts: Sep 8 2008
 
Registration: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16082&eventType=Training%20Course
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.